BEAM vs CAG · rev $63.5M vs P/E 31, rev $11.61B
Beam Therapeutics Inc (BEAM) versus ConAgra Foods Inc (CAG) — a side-by-side from cached financials, not a winner call.
Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.
ConAgra Foods Inc (CAG) is a packaged foods company listed on US.
Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.
Latest reported CAG revenue for 2025-05-25 was $11.61B. Net income was $1.15B. Revenue was down 3.6% from 2024-05-26 to 2025-05-25. CAG currently screens at market cap $10.02B and trailing P/E 30.9.
BEAM currently screens at market cap $2.01B. CAG currently screens at market cap $10.02B and trailing P/E 30.9.
Not investment advice. Open the BEAM and CAG stock pages for the full models.
Not investment advice.